Literature DB >> 20017671

CYP2D7-2D6 hybrid tandems: identification of novel CYP2D6 duplication arrangements and implications for phenotype prediction.

Andrea Gaedigk1, Uwe Fuhr, Charlene Johnson, L Anick Bérard, Dianne Bradford, J Steven Leeder.   

Abstract

AIMS: Allelic variants of cytochrome P450 CYP2D6 (CYP2D6), such as gene deletion, duplication, multiplication and conversion, contribute to the wide range of CYP2D6 activity. Novel gene arrangements were discovered and characterized. MATERIALS &
METHODS: DNA from 32 Caucasian and 59 African-American duplication-positive subjects were analyzed by long-range PCR and genotyping to detect CYP2D7-2D6 hybrid tandem alleles. Novel allelic variants were sequenced and a strategy for the detection and analysis of hybrid genes was refined.
RESULTS: CYP2D7-2D6 hybrid tandem alleles were identified in one African-American and four Caucasian subjects. Three novel hybrid genes were found on CYP2D6*1 and CYP2D6*2 duplication backgrounds and designated CYP2D6*76, *77 and *78. CYP2D7 to 2D6 conversion occurred in introns 1 and 4, and exon 9. All carried a T-insertion in exon 1 abolishing activity. In Caucasians, four out of 33 (12%) of the duplication-positive alleles were hybrid tandems, three CYP2D6*77 + *2 and one CYP2D6*78 + *2. By contrast, in African-Americans only one of 60 duplication-positive alleles was identified as a hybrid tandem. This allele was designated CYP2D6*76 + *1.
CONCLUSION: Hybrid tandem alleles occur infrequently (<0.25%) in Caucasians, but may explain why not every subject with a CYP2D6 duplication presents with an ultrarapid metabolizer phenotype.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20017671      PMCID: PMC6556886          DOI: 10.2217/pgs.09.133

Source DB:  PubMed          Journal:  Pharmacogenomics        ISSN: 1462-2416            Impact factor:   2.533


  21 in total

1.  Optimization of cytochrome P4502D6 (CYP2D6) phenotype assignment using a genotyping algorithm based on allele frequency data.

Authors:  A Gaedigk; R R Gotschall; N S Forbes; S D Simon; G L Kearns; J S Leeder
Journal:  Pharmacogenetics       Date:  1999-12

2.  Pharmacogenetics of morphine poisoning in a breastfed neonate of a codeine-prescribed mother.

Authors:  Gideon Koren; James Cairns; David Chitayat; Andrea Gaedigk; Steven J Leeder
Journal:  Lancet       Date:  2006-08-19       Impact factor: 79.321

3.  CYP2D6 worldwide genetic variation shows high frequency of altered activity variants and no continental structure.

Authors:  Johanna Sistonen; Antti Sajantila; Oscar Lao; Jukka Corander; Guido Barbujani; Silvia Fuselli
Journal:  Pharmacogenet Genomics       Date:  2007-02       Impact factor: 2.089

4.  Cytochrome P4502D6 (CYP2D6) gene locus heterogeneity: characterization of gene duplication events.

Authors:  A Gaedigk; L Ndjountché; K Divakaran; L Dianne Bradford; I Zineh; T F Oberlander; D C Brousseau; D G McCarver; J A Johnson; S W Alander; K Wayne Riggs; J Steven Leeder
Journal:  Clin Pharmacol Ther       Date:  2007-02       Impact factor: 6.875

5.  The CYP2D6 activity score: translating genotype information into a qualitative measure of phenotype.

Authors:  A Gaedigk; S D Simon; R E Pearce; L D Bradford; M J Kennedy; J S Leeder
Journal:  Clin Pharmacol Ther       Date:  2007-10-31       Impact factor: 6.875

6.  The CYP2D6 gene locus in South African Coloureds: unique allele distributions, novel alleles and gene arrangements.

Authors:  Andrea Gaedigk; Christa Coetsee
Journal:  Eur J Clin Pharmacol       Date:  2008-01-17       Impact factor: 2.953

7.  CYP2D6*36 gene arrangements within the cyp2d6 locus: association of CYP2D6*36 with poor metabolizer status.

Authors:  Andrea Gaedigk; L Dianne Bradford; Sarah W Alander; J Steven Leeder
Journal:  Drug Metab Dispos       Date:  2006-01-13       Impact factor: 3.922

Review 8.  Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspects.

Authors:  Magnus Ingelman-Sundberg; Sarah C Sim; Alvin Gomez; Cristina Rodriguez-Antona
Journal:  Pharmacol Ther       Date:  2007-10-09       Impact factor: 12.310

9.  Catalytic roles of CYP2D6.10 and CYP2D6.36 enzymes in mexiletine metabolism: in vitro functional analysis of recombinant proteins expressed in Saccharomyces cerevisiae.

Authors:  Nobumitsu Hanioka; Yoshihito Okumura; Yoshiro Saito; Hiroyuki Hichiya; Akiko Soyama; Keita Saito; Kazuyuki Ueno; Jun-ichi Sawada; Shizuo Narimatsu
Journal:  Biochem Pharmacol       Date:  2006-03-09       Impact factor: 5.858

Review 10.  Cytochrome P450 2D6: overview and update on pharmacology, genetics, biochemistry.

Authors:  Ulrich M Zanger; Sebastian Raimundo; Michel Eichelbaum
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-11-15       Impact factor: 3.000

View more
  28 in total

1.  CYP2A6 genotyping methods and strategies using real-time and end point PCR platforms.

Authors:  Catherine A Wassenaar; Qian Zhou; Rachel F Tyndale
Journal:  Pharmacogenomics       Date:  2015-12-15       Impact factor: 2.533

2.  Frequency of undetected CYP2D6 hybrid genes in clinical samples: impact on phenotype prediction.

Authors:  John Logan Black; Denise L Walker; Dennis J O'Kane; Maria Harmandayan
Journal:  Drug Metab Dispos       Date:  2011-10-17       Impact factor: 3.922

3.  Sources of Interindividual Variability.

Authors:  Yvonne S Lin; Kenneth E Thummel; Brice D Thompson; Rheem A Totah; Christi W Cho
Journal:  Methods Mol Biol       Date:  2021

4.  Detection of an endogenous urinary biomarker associated with CYP2D6 activity using global metabolomics.

Authors:  Jessica Tay-Sontheimer; Laura M Shireman; Richard P Beyer; Taurence Senn; Daniela Witten; Robin E Pearce; Andrea Gaedigk; Cletus L Gana Fomban; Justin D Lutz; Nina Isoherranen; Kenneth E Thummel; Oliver Fiehn; J Steven Leeder; Yvonne S Lin
Journal:  Pharmacogenomics       Date:  2014-12       Impact factor: 2.533

Review 5.  PharmVar GeneFocus: CYP2D6.

Authors:  Charity Nofziger; Amy J Turner; Katrin Sangkuhl; Michelle Whirl-Carrillo; José A G Agúndez; John L Black; Henry M Dunnenberger; Gualberto Ruano; Martin A Kennedy; Michael S Phillips; Houda Hachad; Teri E Klein; Andrea Gaedigk
Journal:  Clin Pharmacol Ther       Date:  2019-12-09       Impact factor: 6.875

6.  Estimation of the minimum effective dose of tramadol for postoperative analgesia in infants using the continual reassessment method.

Authors:  Yue'e Dai; Dongxu Lei; Zhenghua Huang; Yan Yin; G Allen Finley; Yunxia Zuo
Journal:  Front Med       Date:  2012-08-10       Impact factor: 4.592

7.  Pharmacogenetics in American Indian populations: analysis of CYP2D6, CYP3A4, CYP3A5, and CYP2C9 in the Confederated Salish and Kootenai Tribes.

Authors:  Alison Fohner; LeeAnna I Muzquiz; Melissa A Austin; Andrea Gaedigk; Adam Gordon; Timothy Thornton; Mark J Rieder; Mark A Pershouse; Elizabeth A Putnam; Kevin Howlett; Patrick Beatty; Kenneth E Thummel; Erica L Woodahl
Journal:  Pharmacogenet Genomics       Date:  2013-08       Impact factor: 2.089

8.  CYP2D6 Haplotype Determination Using Long Range Allele-Specific Amplification: Resolution of a Complex Genotype and a Discordant Genotype Involving the CYP2D6*59 Allele.

Authors:  Andrea Gaedigk; Amanda K Riffel; J Steven Leeder
Journal:  J Mol Diagn       Date:  2015-09-01       Impact factor: 5.568

9.  Common CYP2D6 polymorphisms affecting alternative splicing and transcription: long-range haplotypes with two regulatory variants modulate CYP2D6 activity.

Authors:  Danxin Wang; Ming J Poi; Xiaochun Sun; Andrea Gaedigk; J Steven Leeder; Wolfgang Sadee
Journal:  Hum Mol Genet       Date:  2013-08-28       Impact factor: 6.150

10.  Single dose, CYP2D6 genotype-stratified pharmacokinetic study of atomoxetine in children with ADHD.

Authors:  J T Brown; S M Abdel-Rahman; L van Haandel; A Gaedigk; Y S Lin; J S Leeder
Journal:  Clin Pharmacol Ther       Date:  2016-01-12       Impact factor: 6.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.